Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend]
SEC Accession No. 0001213900-24-033418
Filing Date
2024-04-16
Accepted
2024-04-16 16:01:29
Documents
17
Period of Report
2023-12-31

Document Format Files

Seq Description Document Type Size
1 AMENDMENT NO. 1 TO FORM 10-K ea0203836-10ka1_inmune.htm   iXBRL 10-K/A 260973
2 CERTIFICATION ea020383601ex31-3_inmune.htm EX-31.3 4420
3 CERTIFICATION ea020383601ex31-4_inmune.htm EX-31.4 4375
  Complete submission text file 0001213900-24-033418.txt   540092

Data Files

Seq Description Document Type Size
4 XBRL SCHEMA FILE inmb-20231231.xsd EX-101.SCH 3211
5 XBRL DEFINITION FILE inmb-20231231_def.xml EX-101.DEF 17728
6 XBRL LABEL FILE inmb-20231231_lab.xml EX-101.LAB 36846
7 XBRL PRESENTATION FILE inmb-20231231_pre.xml EX-101.PRE 18869
20 EXTRACTED XBRL INSTANCE DOCUMENT ea0203836-10ka1_inmune_htm.xml XML 8422
Mailing Address 225 NE MIZNER BLVD, SUITE 640 BOCA RATON FL 33432
Business Address 225 NE MIZNER BLVD, SUITE 640 BOCA RATON FL 33432 8589643720
Inmune Bio, Inc. (Filer) CIK: 0001711754 (see all company filings)

EIN.: 475205835 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 10-K/A | Act: 34 | File No.: 001-38793 | Film No.: 24847773
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)